BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30266945)

  • 1. DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation.
    Bean GR; Anderson J; Sangoi AR; Krings G; Garg K
    Mod Pathol; 2019 Feb; 32(2):280-289. PubMed ID: 30266945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors.
    Momeni Boroujeni A; Kertowidjojo E; Wu X; Soslow RA; Chiang S; Da Silva EM; Weigelt B; Chui MH
    Mod Pathol; 2022 Nov; 35(11):1684-1694. PubMed ID: 36138078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent TP53 Pathway Alterations and Aggressive Behavior.
    Hodgson A; Amemiya Y; Seth A; Djordjevic B; Parra-Herran C
    Am J Surg Pathol; 2017 Nov; 41(11):1513-1522. PubMed ID: 28834809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma.
    de Kock L; Yoon JY; Apellaniz-Ruiz M; Pelletier D; McCluggage WG; Stewart CJR; Dickson BC; Rouzbahman M; Clarke BA; Foulkes WD
    Mod Pathol; 2020 Jun; 33(6):1207-1219. PubMed ID: 31900434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological analysis of 22 Müllerian adenosarcomas and the sequencing of DICER1 mutation.
    Yao X; Wang W; He Y
    Diagn Pathol; 2024 Apr; 19(1):56. PubMed ID: 38570882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial Stem/Progenitor cell (ES/PC) Marker Expression Profile in Adenosarcoma and Endometrial Stromal Sarcoma.
    Yoon JY; de Kock L; Stewart CJR; McCluggage WG; Foulkes WD; Clarke BA; Rouzbahman M
    Cancer Treat Res Commun; 2021; 27():100363. PubMed ID: 33838572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.
    Conlon N; Schultheis AM; Piscuoglio S; Silva A; Guerra E; Tornos C; Reuter VE; Soslow RA; Young RH; Oliva E; Weigelt B
    Mod Pathol; 2015 Dec; 28(12):1603-12. PubMed ID: 26428316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing.
    Apellaniz-Ruiz M; McCluggage WG; Foulkes WD
    Genes Chromosomes Cancer; 2021 Mar; 60(3):217-233. PubMed ID: 33135284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations.
    Bennett JA; Ordulu Z; Young RH; Pinto A; Van de Vijver K; Burandt E; Wanjari P; Shah R; de Kock L; Foulkes WD; McCluggage WG; Ritterhouse LL; Oliva E
    Mod Pathol; 2021 Sep; 34(9):1750-1762. PubMed ID: 34017064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
    Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
    Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine adenosarcomas are mesenchymal neoplasms.
    Piscuoglio S; Burke KA; Ng CK; Papanastasiou AD; Geyer FC; Macedo GS; Martelotto LG; de Bruijn I; De Filippo MR; Schultheis AM; Ioris RA; Levine DA; Soslow RA; Rubin BP; Reis-Filho JS; Weigelt B
    J Pathol; 2016 Feb; 238(3):381-8. PubMed ID: 26592504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomewide copy number analysis of Müllerian adenosarcoma identified chromosomal instability in the aggressive subgroup.
    Lee JC; Lu TP; Changou CA; Liang CW; Huang HN; Lauria A; Huang HY; Lin CY; Chiang YC; Davidson B; Lin MC; Kuo KT
    Mod Pathol; 2016 Sep; 29(9):1070-82. PubMed ID: 27255164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
    Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
    Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
    El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
    Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
    Yang B; Chour W; Salazar CG; Zamiara P; Schmidt RJ; Raca G; Shillingford N; Zhou S; Warren M; Parham DM; Pawel B; Wang LL
    Am J Surg Pathol; 2024 Feb; 48(2):194-203. PubMed ID: 37946548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract.
    Friedlander ML; Covens A; Glasspool RM; Hilpert F; Kristensen G; Kwon S; Selle F; Small W; Witteveen E; Russell P
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S78-82. PubMed ID: 25341585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine adenosarcoma with rhabdomyosarcomatous overgrowth. Brief communication.
    Yilmaz F; Ozdemir N; Akalin T; Veral A; Dikmen Y; Erhan Y
    Eur J Gynaecol Oncol; 2000; 21(4):430-2. PubMed ID: 11055503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine adenosarcoma: Clinical significance of histological classification and SNP array analysis.
    Ngo C; Cotteret S; Deneche I; Kfoury M; Chehab R; Tran-Dien A; Vibert J; Leary A; Gouy S; Maulard A; Morice P; Scoazec JY; Pautier P; Genestie C
    Hum Pathol; 2024 Jun; 148():14-22. PubMed ID: 38688412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
    Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
    N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplastic sarcomas of the kidney are characterized by DICER1 mutations.
    Wu MK; Vujanic GM; Fahiminiya S; Watanabe N; Thorner PS; O'Sullivan MJ; Fabian MR; Foulkes WD
    Mod Pathol; 2018 Jan; 31(1):169-178. PubMed ID: 28862265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.